Table 3.
MSNA and cardiovascular variables at baseline and during lower body negative pressure (LBNP)
| Stimulus | 2-way RM ANOVA P-value | ||||||
|---|---|---|---|---|---|---|---|
| Variable | Group | Baseline | LBNP −15 | LBNP −30 | Group | Time point | Interaction |
| MSNA, bursts·min−1 | YG (n=12) | 10 ± 1 | 15 ± 2 | 22 ± 3 | 0.004 | <0.001 | 0.237 |
| MA/O (n=10) | 25 ± 4 | 30 ± 4 | 33 ± 5 | ||||
| MSNA, bursts·100hb−1 | YG (n=12) | 17 ± 2 | 24 ± 3 | 32 ± 5 | <0.001 | <0.001 | 0.280 |
| MA/O (n=10) | 45 ± 7 | 53 ± 7 | 57 ± 8 | ||||
| MSNA, AU·min−1 | YG (n=12) | 490 ± 66 | 780 ± 101 | 1317 ± 293 | 0.021 | <0.001 | 0.655 |
| MA/O (n=10) | 1180 ± 221 | 1611 ± 233 | 1871 ± 408 | ||||
| Norepinephrine, pg·mL−1 | YG (n=12) | 211 ± 34 | 221 ± 20 | 306 ± 37 | <0.001 | <0.001 | 0.003 |
| MA/O (n=13) | 298 ± 34 | 552 ± 47*† | 598 ± 68*† | ||||
| Systolic BP, mmHg | YG (n=15) | 113 ± 2 | 112 ± 3 | 112 ± 3 | 0.520 | <0.001 | 0.135 |
| MA/O (n=14) | 117 ± 3 | 117 ± 4 | 112 ± 4 | ||||
| Diastolic BP, mmHg | YG (n=15) | 68 ± 1 | 68 ± 1 | 71 ± 1* | 0.165 | 0.272 | 0.049 |
| MA/O (n=14) | 73 ± 2 | 73 ± 3 | 72 ± 3 | ||||
| Mean BP, mmHg | YG (n=15) | 83 ± 1 | 83 ± 2 | 84 ± 2 | 0.248 | 0.722 | 0.038 |
| MA/O (n=14) | 88 ± 2 | 88 ± 3 | 86 ± 3 | ||||
| Heart rate, beats·min−1 | YG (n=15) | 59 ± 2 | 61 ± 2 | 68 ± 3# | 0.028 | <0.001 | 0.021 |
| MA/O (n=14) | 54 ± 2 | 55 ± 3 | 58 ± 3#† | ||||
Values are means ± SE. YG, young adults; MA/O, middle-age/older adults; MSNA, muscle sympathetic nerve activity; AU, arbitrary units; BP, arterial blood pressure;
P<0.05 vs. baseline,
P<0.05 vs. baseline and LBNP −15mmHg;
P<0.05 vs. YG; Holm-Sidak post hoc did not detect significant differences between YG and MA/O in mean BP during LBNP despite 2-way RM ANOVA significant interaction.